Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Charles Willis Lugar"'
Autor:
Kristy Kikly, Howard Barff Broughton, William Chang, Selma Sapmaz, Richard Morphy, Holly A. Bina, Jim D. Durbin, Sherry Y Guo, Timothy Ivo Richardson, Jimmy P Steele, Ryan Edward Stites, Brian G. Getman, Vaught Grant Matthews, Veavi Ching-Yun Chang, Pamela K. Shetler, Greg L Durst, Denise D Edmondson, Rob Barr, Helene Rudyk, Charles Willis Lugar, Nita J. Patel, Christian Alexander Clarke, Kelly Wayne Furness, Nicole E New, David K. Clawson, Keith R. Stayrook, Mark Chambers, Brian Michael Mathes, Stephanie L. Stout, Wendy H. Gough
Publikováno v:
Journal of Medicinal Chemistry. 64:5470-5484
The Th17 pathway has been implicated in autoimmune diseases. The retinoic acid receptor-related orphan receptor C2 (RORγt) is a master regulator of Th17 cells and controls the expression of IL-17A. RORγt is expressed primarily in IL-17A-producing l
Autor:
Timothy Ivo Richardson, Chahrzad Montrose-Rafizadeh, Scott Alan Jones, Terry L. Moore, Thomas J. Bleisch, John J. Osborne, Charles Willis Lugar, Yu Kuo-Long, Jeffrey Alan Dodge, Pamela K. Shetler, Nita J. Patel, Christian Alexander Clarke, Andrew G. Geiser, Jose Eduardo Lopez, Rachelle J. Sells Galvin, Brian Stephen Muehl, Ying K. Yee, Norman Earle Hughes, Richard W. Zink
Publikováno v:
ACS Medicinal Chemistry Letters. 2:148-153
We report the synthesis and characterization of novel 3-aryl indoles as potent and efficacious progesterone receptor (PR) antagonists with potential for the treatment of uterine fibroids. These compounds demonstrated excellent selectivity over other
Publikováno v:
Combinatorial Chemistry & High Throughput Screening. 9:175-180
Growth hormone secretagogues (GHSs) are synthetic molecules that stimulate and amplify pulsatile pituitary growth hormone release, via a separate pathway distinct from GH releasing hormone/somatostatin. The activity of GHSs is not fully specific for
Autor:
Mark L. Heiman, Andrea L. Woodson, Terry D. Lindstrom, David L. Smiley, Jeffrey Alan Dodge, Michael P. Clay, Charles Willis Lugar
Publikováno v:
Bioorganic & Medicinal Chemistry Letters. 14:5873-5876
2-(2-Amino-2-methyl-propionylamino)-5-phenyl-pentanoic acid [1-[1-(4-methoxy-phenyl)-1-methyl-2-oxo-2-pyrrolidin-1-yl-ethyl]-1H-imidazol-4-yl]-amide (LY444711, 6) is an orally active ghrelin agonist that binds with high affinity to and is a potent ac
Autor:
Magee David Edward, Jeffrey Alan Dodge, Pamela K. Shetler, Mary D. Adrian, Henry Uhlman Bryant, Charles Willis Lugar
Publikováno v:
Bioorganic & Medicinal Chemistry Letters. 13:4281-4284
The pharmacology and SAR of representative equine estogens is described. 17alpha-Dihydroequilenin was found to prevent bone loss after 5 weeks of oral administration to ovariectomized rats. The stereochemical significance of the D-ring and the C/D ri
Autor:
Joseph H. Kennedy, V. Scott Sharp, Timothy Alan Shepherd, Jeffrey Alan Dodge, John L Bowers, Charles Willis Lugar
Publikováno v:
Journal of Chromatography A. 872:75-84
Chromatographic separations of new growth hormone secretagogue compounds were developed to support structure–activity relationship (SAR) studies in conjunction with lead optimization. These new compounds differed from Merck’s MK-677 by having two
Autor:
Robert M. Amos, Yong Wang, Peter Stanley Borromeo, Robert J. Barr, Timothy Ivo Richardson, Gregory L. Durst, Jeffrey Alan Dodge, Harold E. Osborne, Bryan H. Norman, Scott Alan Jones, Chahrzad Montrose-Rafizadeh, and Amechand Boodhoo, Keyue Chen, Sherry Guo, Charles Willis Lugar, Venkatesh Krishnan
Publikováno v:
Journal of Medicinal Chemistry. 49:6155-6157
Benzopyran selective estrogen receptor beta agonist-1 (SERBA-1) shows potent, selective binding and agonist function in estrogen receptor beta (ERbeta) in vitro assays. X-ray crystal structures of SERBA-1 in ERalpha and beta help explain observed bet
Autor:
John J. Osborne, Charles A. Frolik, Charles Willis Lugar, Andrew L. Glasebrook, Jeffrey Alan Dodge, David Lynn Phillips, Stephen Sung Yong Cho
Publikováno v:
Bioorganic & Medicinal Chemistry Letters. 7:993-996
Glucuronide conjugates 1 and 2, the major metabolites of raloxifene, have been prepared and their molecular interactions with the estrogen receptor determined.
Autor:
Andrew L. Glasebrook, Larry A. Spangle, Lorri L. Short, Stephen Sung Yong Cho, David Lynn Phillips, Masahiko Sato, Jeffrey Alan Dodge, John J. Osborne, Charles A. Frolik, Henry Uhlman Bryant, Na N. Yang, Martin Michael John, Charles Willis Lugar
Publikováno v:
The Journal of Steroid Biochemistry and Molecular Biology. 61:97-106
Raloxifene (LY139481 HCl) is a selective estrogen receptor modulator (SERM) which blocks the effects of estrogen on some tissues, such as the breast and uterus, while mimicking estrogen in other tissues, such as bone. To study the origins of this uni
Autor:
Macklin Brian Arnold, Paul L. Ornstein, D D Schoepp, J. D. Leander, Charles Willis Lugar, Peter Stanley Borromeo, David Lodge, N. K. Allen, Thomas J. Bleisch
Publikováno v:
Journal of Medicinal Chemistry. 39:2219-2231
A series of 6-substituted decahydroisoquinoline-3-carboxylic acids were prepared as excitatory amino acid (EAA) receptor antagonists. These compounds are antagonists at the N-methyl-D-aspartate (NMDA) and 2-amino-3-(5-methyl-3-hydroxyisoxazol-4-yl) p